Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of APG-157 With Bevacizumab for Patients With Recurrent High-Grade Glioma

NCT06011109 is registered in ClinicalTrials.gov with Aveta Biomics, Inc. as lead sponsor.

NCT NCT06011109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06011109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of APG-157 With Bevacizumab for Patients With Recurrent High-Grade Glioma
Lead sponsor
Aveta Biomics, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
December 13, 2023
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, glioma